Nina Pavcnik
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Nina Pavcnik has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Pinelopi Koujianou Goldberg
Department of Economics, Yale University
4 shared publications Andreas Blom
1 shared publication- Angelo Costa Gurgel
Center for Sustainability Science and Strategy Massachusetts Institute of Technology Cambridge MA USA
1 shared publication - Berk Özler
World Bank - Development Economics Research Group (DECRG)
1 shared publication - Brian McCaig
Wilfrid Laurier University - School of Business & Economics
1 shared publication - Chris Elbers
Free University Amsterdam and Tinbergen Institute , FEWEB-VU, De Boelelaan 1105, 1081 HV Amsterdam, The Netherlands
1 shared publication
Latest Publications
- 14 July 2021
- Published by Springer Nature in IMF Economic Review
- Vol. 69 (3) , 540-575
Entry and Exit of Informal Firms and Development
- 14 July 2021
- Published by Springer Nature in IMF Economic Review
- Vol. 69 (3) , 540-575
Entry and Exit of Informal Firms and Development
- 1 April 2009
- Published by Oxford University Press (OUP) in Journal of the European Economic Association
- Vol. 7 (2-3) , 498-507
Child Labor and Schooling in A Globalizing World: Some Evidence from Urban India
- 1 April 2009
- Published by Oxford University Press (OUP) in Journal of the European Economic Association
- Vol. 7 (2-3) , 498-507
Child Labor and Schooling in A Globalizing World: Some Evidence from Urban India
- 1 January 2007
- Published by University of Chicago Press
- p. 241-288
The Effects of the Colombian Trade Liberalization on Urban Poverty
This chapter examines the impact of a large reduction in average tariffs in Colombia between 1984 and 1998 on a variety of urban labor market outcomes: the probability of becoming unemployed, minimum wage compliance, informal-sector employment, and the incidence of poverty. The Colombian trade reforms indicate that the cross-sectional variation in tariff changes provides an appealing policy experiment to study how trade policy changes have affected the Colombian economy. Poverty in urban Colombia is highly correlated with unemployment. The chapter shows that the trade policy affected the probability of becoming unemployed. The poverty reduction observed between 1986 and 1994 cannot be attributed to trade-policy-induced changes in informality or to minimum wage compliance. Thus, the descriptive results establish that poverty in urban areas is highly linked with unemployment, employment in the informal sector, and noncompliance with minimum wages.
- 1 January 2007
- Published by University of Chicago Press
- p. 241-288
The Effects of the Colombian Trade Liberalization on Urban Poverty
This chapter examines the impact of a large reduction in average tariffs in Colombia between 1984 and 1998 on a variety of urban labor market outcomes: the probability of becoming unemployed, minimum wage compliance, informal-sector employment, and the incidence of poverty. The Colombian trade reforms indicate that the cross-sectional variation in tariff changes provides an appealing policy experiment to study how trade policy changes have affected the Colombian economy. Poverty in urban Colombia is highly correlated with unemployment. The chapter shows that the trade policy affected the probability of becoming unemployed. The poverty reduction observed between 1986 and 1994 cannot be attributed to trade-policy-induced changes in informality or to minimum wage compliance. Thus, the descriptive results establish that poverty in urban areas is highly linked with unemployment, employment in the informal sector, and noncompliance with minimum wages.
- 1 July 2005
- Published by Wiley in The World Economy
- Vol. 28 (7) , 923-939
Short-term Consequences of Trade Reform for Industry Employment and Wages: Survey of Evidence from Colombia
- 1 July 2005
- Published by Wiley in The World Economy
- Vol. 28 (7) , 923-939
Short-term Consequences of Trade Reform for Industry Employment and Wages: Survey of Evidence from Colombia
- 30 September 2004
- Published by World Bank
World Bank Economic Review 18 (3), Sept 2004
- 27 April 2004
- Published by Elsevier in Journal of Development Economics
- Vol. 74 (2) , 331-366
Trade reforms and wage inequality in Colombia*1
- 27 April 2004
- Published by Elsevier in Journal of Development Economics
- Vol. 74 (2) , 331-366
Trade reforms and wage inequality in Colombia*1
- 1 January 2002
- Published by Wiley in The RAND Journal of Economics
- Vol. 33 (3) , 469-87
Do Pharmaceutical Prices Respond to Potential Patient Out-of-Pocket Expenses?
Despite the importance of patient insurance in the market for prescription pharmaceuticals, little is known about the impact of patient reimbursement on the pricing behavior of pharmaceutical firms. I examine the link between potential patient out-of-pocket expenses and pharmaceutical pricing using a unique policy experiment from Germany. Starting in 1989, a maximum reimbursement for a given medicine replaced a flat prescription fee. This change in reimbursement exposes the patient to the price of a prescribed product. Using a product-level panel data set covering several therapeutic categories before and after the policy change, I find that producers significantly decrease prices after the change in potential patient out-of-pocket expenses. Price declines are most pronounced for brand-name products. Moreover, branded products that face more generic competitors reduce prices more.
- 1 January 2002
- Published by Wiley in The RAND Journal of Economics
- Vol. 33 (3) , 469-87
Do Pharmaceutical Prices Respond to Potential Patient Out-of-Pocket Expenses?
Despite the importance of patient insurance in the market for prescription pharmaceuticals, little is known about the impact of patient reimbursement on the pricing behavior of pharmaceutical firms. I examine the link between potential patient out-of-pocket expenses and pharmaceutical pricing using a unique policy experiment from Germany. Starting in 1989, a maximum reimbursement for a given medicine replaced a flat prescription fee. This change in reimbursement exposes the patient to the price of a prescribed product. Using a product-level panel data set covering several therapeutic categories before and after the policy change, I find that producers significantly decrease prices after the change in potential patient out-of-pocket expenses. Price declines are most pronounced for brand-name products. Moreover, branded products that face more generic competitors reduce prices more.